Allianz Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,015
Closed -$306K 2148
2021
Q4
$306K Sell
6,015
-31
-0.5% -$1.58K ﹤0.01% 1951
2021
Q3
$337K Buy
6,046
+360
+6% +$20.1K ﹤0.01% 1891
2021
Q2
$243K Hold
5,686
﹤0.01% 1844
2021
Q1
$237K Sell
5,686
-720
-11% -$30K ﹤0.01% 1824
2020
Q4
$298K Sell
6,406
-413
-6% -$19.2K ﹤0.01% 1728
2020
Q3
$290K Sell
6,819
-416
-6% -$17.7K ﹤0.01% 1689
2020
Q2
$347K Buy
+7,235
New +$347K ﹤0.01% 1682
2018
Q3
Sell
-28,300
Closed -$2.14M 2230
2018
Q2
$2.14M Sell
28,300
-105,722
-79% -$8M ﹤0.01% 1502
2018
Q1
$7.06M Buy
134,022
+410
+0.3% +$21.6K 0.01% 1097
2017
Q4
$7.14M Buy
133,612
+7,360
+6% +$393K 0.01% 1111
2017
Q3
$7.53M Sell
126,252
-21,924
-15% -$1.31M 0.01% 1059
2017
Q2
$11.7M Sell
148,176
-16,083
-10% -$1.27M 0.01% 934
2017
Q1
$13.6M Buy
164,259
+62,223
+61% +$5.16M 0.01% 895
2016
Q4
$8.1M Sell
102,036
-6,472
-6% -$513K 0.01% 1066
2016
Q3
$7.6M Sell
108,508
-32,777
-23% -$2.29M 0.01% 1072
2016
Q2
$5.48M Sell
141,285
-125,062
-47% -$4.85M 0.01% 1101
2016
Q1
$10.8M Sell
266,347
-28,424
-10% -$1.15M 0.01% 892
2015
Q4
$26.1M Sell
294,771
-61,784
-17% -$5.48M 0.03% 558
2015
Q3
$26.4M Buy
356,555
+28,099
+9% +$2.08M 0.03% 554
2015
Q2
$26.6M Buy
328,456
+35,579
+12% +$2.88M 0.03% 591
2015
Q1
$12.3M Buy
292,877
+148,253
+103% +$6.21M 0.01% 755
2014
Q4
$2.24M Sell
144,624
-1,475
-1% -$22.9K ﹤0.01% 1207
2014
Q3
$1.85M Buy
146,099
+23,055
+19% +$292K ﹤0.01% 1235
2014
Q2
$1.76M Sell
123,044
-2,896
-2% -$41.5K ﹤0.01% 1238
2014
Q1
$1.61M Buy
+125,940
New +$1.61M ﹤0.01% 1268